Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.

[1]  P. Pushko,et al.  Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice. , 2017, Virology.

[2]  W. Chiu,et al.  Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge , 2017, Journal of Virology.

[3]  K. Kehn-Hall,et al.  Ablation of Programmed −1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity , 2016, Journal of Virology.

[4]  Ronan N. Rouxel,et al.  Attenuated Infectious Hematopoietic Necrosis Virus with Rearranged Gene Order as Potential Vaccine , 2016, Journal of Virology.

[5]  S. Weaver,et al.  DNA-launched live-attenuated vaccines for biodefense applications , 2016, Expert review of vaccines.

[6]  E. Wang,et al.  IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge , 2015, PLoS neglected tropical diseases.

[7]  I. Lukashevich,et al.  Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice. , 2014, Virology.

[8]  E. Wang,et al.  DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice. , 2014, The Journal of infectious diseases.

[9]  U. Balasuriya,et al.  Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses , 2013, Clinical and experimental vaccine research.

[10]  E. Wang,et al.  Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. , 2013, Vaccine.

[11]  C. Rossi,et al.  Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83) , 2012, Human vaccines & immunotherapeutics.

[12]  John A. Vaughn,et al.  Update on immunizations in adults. , 2011, American family physician.

[13]  M. Vignuzzi,et al.  Arbovirus high fidelity variant loses fitness in mosquitoes and mice , 2011, Proceedings of the National Academy of Sciences.

[14]  B. Geiss,et al.  Infectious alphavirus production from a simple plasmid transfection+ , 2011, Virology Journal.

[15]  C. Schmaljohn,et al.  A DNA Vaccine for Venezuelan Equine Encephalitis Virus Delivered by Intramuscular Electroporation Elicits High Levels of Neutralizing Antibodies in Multiple Animal Models and Provides Protective Immunity to Mice and Nonhuman Primates , 2011, Clinical and Vaccine Immunology.

[16]  E. Wang,et al.  Stability of RNA virus attenuation approaches. , 2011, Vaccine.

[17]  Pamela J. Glass,et al.  Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development. , 2011, Vaccine.

[18]  C. Schmaljohn,et al.  Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates. , 2010, Vaccine.

[19]  D. Fine,et al.  Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus. , 2010, Vaccine.

[20]  D. Fine,et al.  A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV). , 2010, Journal of virological methods.

[21]  D. Fine,et al.  Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. , 2010, Vaccine.

[22]  S. Weaver,et al.  Vaccines for Venezuelan equine encephalitis. , 2009, Vaccine.

[23]  D. Vaughn,et al.  Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases. , 2007, Vaccine.

[24]  B. Murphy,et al.  An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trials. , 2007, Journal of virological methods.

[25]  D. Fine,et al.  Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. , 2007, Vaccine.

[26]  J. Grabenstein,et al.  Immunization to protect the US Armed Forces: heritage, current practice, and prospects. , 2006, Epidemiologic reviews.

[27]  Slobodan Paessler,et al.  Replication and Clearance of Venezuelan Equine Encephalitis Virus from the Brains of Animals Vaccinated with Chimeric SIN/VEE Viruses , 2006, Journal of Virology.

[28]  C. Hoke.  History of U.S. military contributions to the study of viral encephalitis. , 2005, Military medicine.

[29]  A. Brault,et al.  Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Barrera,et al.  Venezuelan equine encephalitis. , 2003, Annual review of entomology.

[31]  R. Johnston,et al.  Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. , 2003, Vaccine.

[32]  Slobodan Paessler,et al.  Recombinant Sindbis/Venezuelan Equine Encephalitis Virus Is Highly Attenuated and Immunogenic , 2003, Journal of Virology.

[33]  D. J. Nisbet,et al.  DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Schoeb,et al.  Vesicular Stomatitis Viruses with Rearranged Genomes Have Altered Invasiveness and Neuropathogenesis in Mice , 2003, Journal of Virology.

[35]  P. Jahrling,et al.  Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses , 2001, Journal of Virology.

[36]  G. Ludwig,et al.  Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors. , 1999, Vaccine.

[37]  S. Weaver,et al.  Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks. , 1999, The American journal of tropical medicine and hygiene.

[38]  A. J. Wright,et al.  TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus. , 1999, Vaccine.

[39]  K. Davis,et al.  Comparative Neurovirulence and Tissue Tropism of Wild-type and Attenuated Strains of Venezuelan Equine Encephalitis Virus Administered by Aerosol in C3H/HeN and BALB/c Mice , 1998, Veterinary pathology.

[40]  C. Peters,et al.  Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. , 1996, Vaccine.

[41]  R. Johnston,et al.  Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. , 1995, Virology.

[42]  J. H. Strauss,et al.  The alphaviruses: gene expression, replication, and evolution , 1994, Microbiological reviews.

[43]  T. Scott,et al.  Diversity within natural populations of eastern equine encephalomyelitis virus. , 1993, Virology.

[44]  J. Roehrig,et al.  Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein , 1993, Journal of virology.

[45]  R. Johnston,et al.  In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. , 1989, Virology.

[46]  E. Cupp,et al.  Vector competence of Culex (Melanoconion) taeniopus for allopatric and epizootic Venezuelan equine encephalomyelitis viruses. , 1987, The American journal of tropical medicine and hygiene.

[47]  D. Baltimore,et al.  Cloned poliovirus complementary DNA is infectious in mammalian cells. , 1981, Science.

[48]  D. Trainer,et al.  SEROLOGIC EVIDENCE OF VENEZUELAN EQUINE ENCEPHALITIS IN SOME WILD AND DOMESTIC POPULATIONS OF SOUTHERN TEXAS , 1975, Journal of wildlife diseases.

[49]  W. S. Gochenour,et al.  Studies on the virus of Venezuelan equine encephalomyelitis. II. Modification by specific immune serum of response of central nervous system of mice. , 1961, Journal of immunology.

[50]  W. D. Tigertt,et al.  ATTENUATION OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS BY IN VITRO CULTIVATION IN GUINEA-PIG HEART CELLS , 1961 .